Page last updated: 2024-11-01

nifedipine and Nesidioblastosis

nifedipine has been researched along with Nesidioblastosis in 1 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Nesidioblastosis: An inherited autosomal recessive syndrome characterized by the disorganized formation of new islets in the PANCREAS and CONGENITAL HYPERINSULINISM. It is due to focal hyperplasia of pancreatic ISLET CELLS budding off from the ductal structures and forming new islets of Langerhans. Mutations in the islet cells involve the potassium channel gene KCNJ11 or the ATP-binding cassette transporter gene ABCC8, both on CHROMOSOME 11.

Research Excerpts

ExcerptRelevanceReference
"We report a newborn infant with persistent hyperinsulinemic hypoglycemia whom we successfully treated with oral nifedipine alone after surgical therapies."5.39Treatment of hyperinsulinemic hypoglycemia because of diffuse nesidioblastosis with nifedipine after surgical therapies in a newborn. ( Keskin, M; Koklu, E; Koklu, S; Ozkan, KU; Sayar, H, 2013)
"We report a newborn infant with persistent hyperinsulinemic hypoglycemia whom we successfully treated with oral nifedipine alone after surgical therapies."1.39Treatment of hyperinsulinemic hypoglycemia because of diffuse nesidioblastosis with nifedipine after surgical therapies in a newborn. ( Keskin, M; Koklu, E; Koklu, S; Ozkan, KU; Sayar, H, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koklu, E1
Ozkan, KU1
Sayar, H1
Koklu, S1
Keskin, M1

Other Studies

1 other study available for nifedipine and Nesidioblastosis

ArticleYear
Treatment of hyperinsulinemic hypoglycemia because of diffuse nesidioblastosis with nifedipine after surgical therapies in a newborn.
    Journal of pediatric endocrinology & metabolism : JPEM, 2013, Volume: 26, Issue:11-12

    Topics: Combined Modality Therapy; Congenital Hyperinsulinism; Humans; Infant, Newborn; Male; Nesidioblastos

2013